稳定的心脏移植受者从山地明转换为新山地明。 - Suppr | 超能文献

Conversion from Sandimmune to Neoral in stable heart transplant recipients.

作者信息

Pethig K, Ruhparwar A, Korn A, Christians U, Wahlers T

机构信息

Division of Thoracic and Cardiovascular Surgery, Hannover Medical School, Germany.

出版信息

Transplant Proc. 1996 Aug;28(4):2287-9.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Conversion from Sandimmune to Neoral in stable heart transplant recipients.稳定的心脏移植受者从山地明转换为新山地明。

Transplant Proc. 1996 Aug;28(4):2287-9.

2

Changing stable heart transplant recipients from Sandimmune to Neoral.将心脏移植稳定受者从山地明转换为新山地明。

Transplant Proc. 1996 Aug;28(4):2285-6.

3

Follow-up after conversion to Neoral in stable heart transplant recipients.稳定的心脏移植受者转换为新山地明后的随访。

Transplant Proc. 1996 Aug;28(4):2282-4.

4

Conversion from Sandimmune to Neoral in stable renal and pancreas transplant recipients enhances cyclosporine absorption.

Transplant Proc. 1996 Aug;28(4):2293-5.

5

Pharmacokinetic, hemodynamic, and metabolic effects of cyclosporine sandimmune versus the microemulsion neoral in heart transplant recipients.心脏移植受者中环孢素山地明与微乳剂新山地明的药代动力学、血流动力学及代谢效应比较

J Heart Lung Transplant. 1997 Aug;16(8):787-94.

6

Conversion from cyclosporine to Neoral in pediatric recipients for kidney, liver, and heart transplantation.小儿肾、肝和心脏移植受者从环孢素转换为新山地明的情况。

Transplant Proc. 1996 Aug;28(4):2262-3.

7

Neoral conversion study: shift from Sandimmune classic formulation to Neoral in heart and lung transplant patients.

Transplant Proc. 1996 Aug;28(4):2281.

8

Comparative bioavailability of Neoral and Sandimmune in cardiac transplant recipients over 1 year.新山地明与环孢素在心脏移植受者中的相对生物利用度：1年研究

Transplant Proc. 1998 Aug;30(5):1892-4. doi: 10.1016/s0041-1345(98)00472-2.

9

Pharmacokinetics of oral cyclosporine (Neoral) in heart transplant recipients during the immediate period after surgery.心脏移植受者术后即刻口服环孢素（新山地明）的药代动力学

Transpl Int. 2002 Dec;15(12):649-54. doi: 10.1007/s00147-002-0491-0. Epub 2002 Nov 22.

10

Comparison of the long-term tolerability, pharmacodynamics, and safety of Sandimmune and Neoral in liver transplant recipients. Ontario Liver Transplant Study Group.肝移植受者中赛尼哌与新山地明的长期耐受性、药效学及安全性比较。安大略肝移植研究组

Transplant Proc. 1996 Aug;28(4):2232-3.

引用本文的文献

1

Cyclosporin: an updated review of the pharmacokinetic properties, clinical efficacy and tolerability of a microemulsion-based formulation (neoral)1 in organ transplantation.环孢素：基于微乳剂的制剂（新山地明）在器官移植中药物动力学特性、临床疗效及耐受性的最新综述

Drugs. 2001;61(13):1957-2016. doi: 10.2165/00003495-200161130-00006.